CV Risk in Rheumatic Disease

Slideshow

(1) Inflammatory diseases raise risk of venous thromboembolism; (2) antiphospholipid antibodies play a role in MI; (3) persistent hyperuricemia predicts mortality.

Recent Videos
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
Signs and Symptoms of Connective Tissue Disease
Connective Tissue Disease Brings Dermatology & Rheumatology Together
Related Content
Methotrexate/Hydroxychloroquine Combo Beats MTX Alone in Rheumatoid Arthritis Treatment

Methotrexate/Hydroxychloroquine Combo Beats MTX Alone in Rheumatoid Arthritis Treatment

Victoria Johnson
September 6th 2024
Article
Emerging Agents in the Treatment of Rheumatic Diseases

Emerging Agents in the Treatment of Rheumatic Diseases

Nehad Soloman, MD, FACR;Andrew Sharobeem, DO, FACR;Philip J. Mease, MD
October 2nd 2023
Podcast
Machine Learning Effectively Characterizes Rheumatoid Arthritis Subtypes

Machine Learning Effectively Characterizes Rheumatoid Arthritis Subtypes

Victoria Johnson
September 4th 2024
Article
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Nehad Soloman, MD, FACR;Andrew Sharobeem, DO, FACR;John B. Boone, MD, FACR;Madelaine Feldman MD, FACR
August 31st 2023
Podcast
New Research Identifies Genes Associated With Gout RIsk

New Research Identifies Genes Associated With Gout RIsk

Victoria Johnson
August 30th 2024
Article
Clinical quiz thumbnail from HCPLive.

Clinical Quiz: Gout Flare Management Recommendations from 2020 ACR Guidelines

HCPLive Editorial Staff
August 29th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.